| NCT05719311 | Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis | COMPLETED | PHASE2 | 2023-02-01 | 2023-07-28 | 2023-06-20 |
| NCT04542434 | Niclosamide in COVID-19 | WITHDRAWN | PHASE2 | 2022-01-20 | 2022-01-20 | 2022-01-20 |
| NCT04436458 | Niclosamide In Moderate COVID-19 | WITHDRAWN | PHASE2 | 2022-01-20 | 2022-01-20 | 2022-01-20 |
| NCT04858425 | Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection | TERMINATED | PHASE2 | 2021-04-30 | 2023-09-10 | 2022-06-04 |
| NCT04839575 | Study of Latiglutenase in T1D/CD Patients | TERMINATED | PHASE2 | 2021-04-06 | 2022-12-19 | 2022-12-19 |
| NCT04375878 | OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis | COMPLETED | PHASE2 | 2020-07-20 | 2021-04-08 | 2021-04-08 |
| NCT04243551 | Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients | TERMINATED | PHASE2 | 2019-11-01 | 2023-10-31 | 2023-10-16 |
| NCT03746483 | OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | COMPLETED | PHASE2 | 2019-01-10 | 2019-07-27 | 2019-07-13 |
| NCT03521232 | A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis | TERMINATED | PHASE1, PHASE2 | 2018-05-15 | 2022-10-04 | 2022-09-19 |
| NCT03011931 | Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] | COMPLETED | EARLY_PHASE1 | 2016-03 | 2019-02 | 2019-01 |